Lucid Diagnostics 주식 가격. LUCD - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

가격

0.9615

매수가

0.9304

매도가

0.9615

거래량

390,466

0.9188 일간 변동폭 0.9609

0.6301 52주 범위 1.50

market_cap

57.058M

전일 종가

0.9239

개장가

0.9299

최근 거래 시간

100

0.9615

(formt)

마지막 거래 시간

재정 규모

US$ 371,289

VWAP

0.950887

평균 볼륨(3m)

452,910

발행 주식

59,342,479

배당수익률

주가수익률

-1.08

주당순이익(EPS)

-0.89

매출

2.43M

순이익

-52.67M

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically hig... Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard. 더 보기

섹터

Surgical,med Instr,apparatus

산업

Surgical,med Instr,apparatus

본부

Wilmington, Delaware, USA

설립됨

Lucid Diagnostics Inc is listed in the Surgical,med Instr,apparatus sector of the 나스닥 with ticker LUCD. The last closing price for Lucid Diagnostics was US$0.92. Over the last year, Lucid Diagnostics shares have traded in a share price range of US$ 0.6301 to US$ 1.50.

Lucid Diagnostics currently has 59,342,479 shares in issue. The market capitalisation of Lucid Diagnostics is US$54.83 million. Lucid Diagnostics has a price to earnings ratio (PE ratio) of -1.08.

Form S-8 - Securities to be offered to employees in employee benefit plans

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire NEW YORK, Jan. 13, 2025 Quarterly test volume of over 4,000 tests represented sequential increase of 45 percent NEW...

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule PR Newswire NEW YORK, Dec. 23, 2024 NEW YORK, Dec. 23, 2024 /PRNewswire/ -- Lucid...

Form 8-K - Current report

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters PR Newswire NEW YORK, Dec. 19, 2024 Partnership launched with fully-contracted...

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication PR Newswire NEW YORK, Dec. 11, 2024 Study demonstrates outstanding...

Form D - Notice of Exempt Offering of Securities

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones PR Newswire NEW YORK, Dec. 3, 2024 New convertible debt...

Form 8-K - Current report

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0.1045	12.1936989498	0.857	0.969	0.842229	245330	0.90535535	CS
4	0.1315	15.843373494	0.83	0.969	0.7803	206683	0.86688777	CS
12	-0.0385	-3.85	1	1.12	0.7501	452910	0.89690682	CS
26	0.1615	20.1875	0.8	1.12	0.7201	318812	0.88160361	CS
52	-0.5385	-35.9	1.5	1.5	0.6301	249030	0.90230439	CS
156	-2.0385	-67.95	3	4.0598	0.6301	138582	1.37880358	CS
260	-11.7885	-92.4588235294	12.75	13.5	0.6301	154991	2.52109956	CS

LUCD - Frequently Asked Questions (FAQ)

What is the current Lucid Diagnostics share price?

The current share price of Lucid Diagnostics is US$ 0.9615

How many Lucid Diagnostics shares are in issue?

Lucid Diagnostics has 59,342,479 shares in issue

What is the market cap of Lucid Diagnostics?

The market capitalisation of Lucid Diagnostics is USD 54.83M

What is the 1 year trading range for Lucid Diagnostics share price?

Lucid Diagnostics has traded in the range of US$ 0.6301 to US$ 1.50 during the past year

What is the PE ratio of Lucid Diagnostics?

The price to earnings ratio of Lucid Diagnostics is -1.08

What is the cash to sales ratio of Lucid Diagnostics?

The cash to sales ratio of Lucid Diagnostics is 23.47

What is the reporting currency for Lucid Diagnostics?

Lucid Diagnostics reports financial results in USD

What is the latest annual turnover for Lucid Diagnostics?

The latest annual turnover of Lucid Diagnostics is USD 2.43M

What is the latest annual profit for Lucid Diagnostics?

The latest annual profit of Lucid Diagnostics is USD -52.67M

What is the registered address of Lucid Diagnostics?

The registered address for Lucid Diagnostics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

Which industry sector does Lucid Diagnostics operate in?

Lucid Diagnostics operates in the SURGICAL,MED INSTR,APPARATUS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.71M
REBNReborn Coffee Inc	US$ 3.31 (63.05%)	55.54M
FCUVFocus Universal Inc	US$ 5.87 (56.62%)	1.73M
SOPASociety Pass Inc	US$ 1.54 (56.50%)	13.82M
CYCNCyclerion Therapeutics Inc	US$ 3.92 (54.33%)	82.39M
ENVBEnveric Biosciences Inc	US$ 2.0899 (-46.41%)	1.58M
NIVFNewGenIvf Group Ltd	US$ 0.1489 (-42.51%)	14.91M
GLSTGlobal Star Acquisition Inc	US$ 8.83 (-39.10%)	23.93k
PRPHProPhase Labs Inc	US$ 0.2633 (-38.02%)	900.48k
SPGCSacks Parente Golf Inc	US$ 0.5601 (-37.86%)	7.42M
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.71M
NVDANVIDIA Corporation	US$ 120.07 (-3.67%)	388.53M
RIMEAlgorhythm Holdings Inc	US$ 0.02565 (5.12%)	338.7M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0355 (-11.25%)	236.05M
CLEUChina Liberal Education Holdings Ltd	US$ 0.1938 (30.77%)	234.74M